Mean annualised relapse rate was 040 ( 95 % CI 034-048 ) in patients given placebo and 021 ( 017-025 ) in patients given fingolimod 05 mg : rate ratio 052 ( 95 % CI 040-066 ; p < 00001 ) , corresponding to a reduction of 48 % with fingolimod 05 mg versus placebo .